Menu Close

Aesthetic injectable companies. Firmenich signs strategic partnership agreement with Harmay in China

Biorevitalization

THE WHAT? Fragrance and taste company Firmenich has entered into a strategic partnership with Harmay, a retail brand in China. 

THE DETAILS As part of the agreement Firmenich and Harmay will join forces to contribute to the development of the Fine Fragrance category in China. They will do this by leveraging their respective capabilities to support the development of new fragrance brands, concepts, experiences and models.

Founded in 2008, Harmay is a premium beauty collection store focused on a Gen Z audience. 

Meso Therapy

Ilaria Resta, President, Global Perfumery, Firmenich, said, “As a world leader in fine fragrance, Firmenich is focused on leading the transformation of this industry and creating trends to future-proof the business. After more than 30 years of successful operations in China, this partnership with Harmay serves as a significant enhancement to our capabilities in China and fortifies our ambitions as the partner of choice in the Chinese market.”

THE WHY? Firmenich is looking to bring additional value to highly localized consumer journeys as part of its China expansion plan.

Olivier Viejo, Head of Fine Fragrance, Firmenich China, said, “Thanks to this strategic partnership with HARMAY we are joining forces to incubate brands of tomorrow and leverage our mutual capabilities in consumers insights, digital, creativity and art of perfumery. This will pave the way for more growth in the Fine Fragrance industry both within China and globally.”

Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.

  Aesthetic injectable companies. Prisoners injected with asbestos in Johnson & Johnson-funded study

Key aspects of aesthetic injectable companies include:

  • Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.

  • Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.

  • Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.

  • Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.

  • Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.